RECENT RESEARCH AWARDS

National Center for Research Resources, NIH. Grant No. 3 U24 RR018111-07S1 ARRA “Establishment and Expansion of a SPF Rhesus Colony”, Dr. Rudolf P. Bohm, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 1 R21 RR026006-01A1“Macaque model of TB/AIDS co-infection via natural routes of exposure ”, Dr. Deepak Kaushal, Principal Investigator.

National Center for Research Resources, NIH, Grant No. 5 P20 RR020159-06 “Center for Experimental Infectious Disease Research, Dr. Andrew Lackner, Principal Investigator of a subcontract with Louisiana State University.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 1 R01 AI07606-01A2 “Pathogenesis of Natural SIV and STLV infections in humans”, Dr. Preston Marx, Principal Investigator.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 1 R21 AI080395-01 ARRA award ‘Importance of Antigen Specific Immunoglobulin responses in controlling SIV infection”, Dr. Bapi Pahar, Principal Investigator.

Centers for Disease Control and Prevention, CDC. Grant No. 200-200-M-32313 ‘Devise and evaluate IgG Capyure Enzyme Immunoassy for use as a measure of proportions of Anti-C6 IgG Antibodies present in total IgG serum samples”, Dr. Mario Philipp, Principal Investigator of a subcontract with the CDC.

Path Vaccine Solutions, PATH-“Multiple-Dose Efficacy and Saftey Study of Pneumococcal Combination Vaccine IC47 containing SP2216-1, SP1732-3 and Recombinant Proteins with Aluminum Hydroxide Adjuvant after Instrumuscular Administration and experimental infection in Rhesus Monkeys, Dr. Mario Philipp, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 3 P51 RR000164-48S1 “Tulane National Primate Research Center”, Circumcision Studies, Dr. Benjamin Sachs, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 3 P51 RR000164-48S2 “Tulane National Primate Research Center” ARRA award for Advance Translational Research, Dr. Benjamin Sachs, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 3 P51 RR000164-48S3 “Tulane National Primate Research Center” ARRA award for Advance Translational Research, Dr. Benjamin Sachs, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 3 P51 RR000164-48S4 “Tulane National Primate Research Center” ARRA award for Pilot Studies, Dr. Benjamin Sachs, Principal Investigator.

National Institutes of Diabetes and Digestive and Kidney Diseases, Grant No. 3 RO1 DK076653-02S1 “Non-Human Primate Model of Gluten-Sensitive Enteropathy”, ARRA award supplement to account no. 547100, Dr. Karol Sestak, Principal Investigator.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 1 R01 AI084793-01 “Early Events in Muscosal SIV Pathogenesis”, Dr. Ronald S. Veazey, Principal Investigator.

Gynuity Health Products, “Topical Estriol for Vaginal Health”, Dr. Ronald S. Veazey, Principal Investigator.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 1 R43 AI081392-01 “SEB Immunotherapy: Human Mabs to Toxin and Cytokines”. Dr. Chad Roy, Principal Investigator of a subcontract with Mapp Biopharmaceutical, Inc.

National Center for Research Resources, NIH. Grant No. 1 G20 RR024823-01 “NHP Caging for New Facilities”, Dr. Rudolf Bohm, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 3 P51 RR000164-47S1, “Tulane National Primate Research Center”, Dr. Benjamin Sachs, Principal Investigator.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 4 R33 AI071947-03 “Identification and Preclinical Testing of Microbicides”. Dr. Preston Marx, Principal Investigator of a subcontract agreement with Board of Regents of the University of Wisconsin System.

National Center for Research Resources, NIH. Grant No. 3 P51 RR000164-47S1, “Tulane National Primate Research Center”, Dr. Benjamin Sachs, Principal Investigator.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 4 R33 AI071952-03 “Syndecan Agonists and Antagonists as Microbicides”. Dr. Ronald Veazey, Principal Investigator of a subcontract agreement with The Scripps Research Institute.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 5 UO1 AI075399-02 “Human Antibodies for Therapeutic Intervention of Staph Enterotoxin B Exposure”. Dr. Chad Roy, Principal Investigator of a subcontract agreement with Morphotek, Inc.

CONRAD Grant No. MSA-03-362 “Protective Efficacy of 6% cellulose sulfate (CS) gel against single high (SH) R5/X4 SHIV vaginal challenge”, Dr. Rudolf Bohm, Principal Investigator of a subcontract with Aaron Diamond AIDS Research Center.

The American Foundation for AIDS Research (amfAR), Grant No. 107151-44-RGRL “Animal Model for controlled SIV Infection”, Dr. Cristian Apetrei, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 2 U24 RR018111-06A1 “Establishment and Expansion of SPF Rhesus Colony”, Dr. Rudolf Bohm, Principal Investigator.

Louisiana Board of Regents, Award No. LEQSF(2007-12)-ENH-PKSFI-PRS-02 “Center of Excellence for Vaccine Development”. Dr. Deepak Kaushal, Principal Investigator of a subcontract with Louisiana State University and Agricultural and Mechanical College.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 5 R01 AI041420-13 “Second Receptors for Primate Immunodeficiency Viruses”, Dr. Ronald Veazey, Principal Investigator of a subcontract with Weill Medical College – Cornell University.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 1 U19 AI076982-01 “A Practical Microbicide Based on HIV-1 Entry Inhibitors”, Dr. Ronald Veazey, Principal Investigator of a subcontract with Weill Medical College – Cornell University.

National Institute of Allergy and Infectious Diseases, NIH. Grant No. 1 U19 AI076981-01 “Studies of CCR5 Inhibition to Prevent HIV”, Dr. Ronald Veazey, Principal Investigator of a subcontract with Case Western.

Aeras Global TB Vaccine Foundation, “New Vaccine Approach for Tuberculosis”, Dr. Andrew Lackner, Principal Investigator.

Tulane University. “Research Enhancement Fund Phase II – Non Human Primate Model of Immunosenescence and Vaccination”, Dr. Elizabeth S. Didier, Principal Investigator.

National Center for Research Resources, NIH. Grant No. 2 P51 RR000164-47, Tulane National Primate Research Center, Dr. Benjamin Sachs, Principal Investigator.

BIOQUAL, Inc. “RSV Study”, Dr. Vicki Traina-Dorge, Principal Investigator.

National Institute for Diabetes, Digestive and Kidney Diseases, NIH. Grant No. 1 R01 DK076653-02, “Non Human Primate Model of Gluten-Sensitive Enteropathy”, Dr. Karol Sestak, Principal Investigator.